Innovent Announces First Subject Dosed in the Phase 1 Clinical Trial of Anti-IL-23 Monoclonal Antibody August 31, 2020
Innovent Announces the Results of the Phase 1/2 Clinical Study of PCSK9 Antibody Tafolecimab at the European Society of Cardiology Annual Conference August 30, 2020
MedGenome announces Strategic Collaboration in Parkinson’s Disease with Denali Therapeutics August 26, 2020
Compass Therapeutics Announces Publication in the Journal Science of Preclinical Data Supporting the Potential of CTX-2026, a Novel Antibody to the Butyrophilin BTN3A1, in Ovarian Cancer Tumor Models August 24, 2020
Lyniate and PatientPing Form Strategic Partnership to Ensure Compliance with the CMS E-Notifications Requirements August 19, 2020
Precision BioSciences Receives Fast Track Disease Designation from U.S. Food and Drug Administration for PBCAR0191 Investigational Allogeneic CAR T Cell Therapy August 19, 2020
Innovent and Lilly Announce Expansion of TYVYT® (Sintilimab Injection) Licensing Agreement August 18, 2020